Related Experiment Videos
Ionic and non-ionic contrast media interaction with anticoagulant drugs
Acta Radiologica: Diagnosis
|January 1, 1982
Summary
Radiographic contrast media, like Renografin-60, significantly prolong clotting times, exhibiting anticoagulant effects. This interaction with heparin can extend for hours, impacting clinical use.
Area of Science:
- Biochemistry
- Pharmacology
- Hematology
Background:
- Radiographic contrast media are widely used in medical imaging.
- Potential interactions between contrast media and the hemostatic system are not fully understood.
- Heparin and Dextran-40 are commonly used as anticoagulants or plasma expanders.
Purpose of the Study:
- To investigate the anticoagulant properties of various radiographic contrast media.
- To evaluate the combined effects of contrast media and heparin on clotting times.
- To assess the duration of anticoagulant effects in vivo.
Main Methods:
- Incubation of normal and pathologic human plasmas with contrast media, heparin, Dextran-40, and saline.
- Measurement of clotting times and thrombin times.
- In vivo studies in dogs involving injections of contrast media and heparin.
Main Results:
- Renografin-60 demonstrated significant anticoagulant effects, prolonging clotting times.
- Co-administration of contrast media and heparin resulted in markedly elevated thrombin times.
- Dextran-40 did not show significant anticoagulant properties.
- Ioxaglic and ioxithalamic acids also exhibited anticoagulant properties.
- In dogs, the combined anticoagulant effect of contrast media and heparin persisted for over 6 hours.
Conclusions:
- Certain radiographic contrast media possess inherent anticoagulant properties.
- Interactions between contrast media and heparin can lead to prolonged and significant anticoagulant effects.
- The findings highlight the clinical significance of contrast media interactions with anticoagulant drugs.